Trials / Completed
CompletedNCT00408382
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (planned)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atorvastatin, Lipitor |
Timeline
- First posted
- 2006-12-06
- Last updated
- 2011-11-17
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00408382. Inclusion in this directory is not an endorsement.